tetradecanoylphorbol acetate has been researched along with withanolides in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, W; Zhao, Y | 1 |
Bae, JS; Han, MS; Ku, SK | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and withanolides
Article | Year |
---|---|
Withaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Cell Transformation, Neoplastic; Down-Regulation; Epidermis; Female; Glycolysis; Isocitrate Dehydrogenase; Ketoglutaric Acids; Lactic Acid; Membrane Potential, Mitochondrial; Mice; Mice, Inbred DBA; Mitochondria; Tetradecanoylphorbol Acetate; Withanolides | 2013 |
Withaferin A is an inhibitor of endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Anti-Inflammatory Agents; Blood Coagulation Factors; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Cell Surface; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Withanolides | 2014 |